1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America OTC Drug and Dietary Supplement Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America OTC Drug and Dietary Supplement Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America OTC Drug and Dietary Supplement Market Regional Analysis
6.2 North America OTC Drug and Dietary Supplement Market Revenue 2017-2027 (US$ Million)
6.3 North America OTC Drug and Dietary Supplement Market Forecast Analysis
7. North America OTC Drug and Dietary Supplement Market Analysis – by Product
7.1 Cough and Cold Products
- 7.1.1 Overview
- 7.1.2 Cough and Cold Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Vitamins and Dietary Supplements
- 7.2.1 Overview
- 7.2.2 Vitamins and Dietary Supplements: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Analgesics
- 7.3.1 Overview
- 7.3.2 Analgesics: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Gastrointestinal Products
- 7.4.1 Overview
- 7.4.2 Gastrointestinal Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Sleep Aids
- 7.5.1 Overview
- 7.5.2 Sleep Aids: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Oral Care Products
- 7.6.1 Overview
- 7.6.2 Oral Care Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Ophthalmic Products
- 7.7.1 Overview
- 7.7.2 Ophthalmic Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Antacids
- 7.8.1 Overview
- 7.8.2 Antacids: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.9 Feminine Care
- 7.9.1 Overview
- 7.9.2 Feminine Care: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America OTC Drug and Dietary Supplement Market Analysis – by Type
8.1 Branded and Generic
- 8.1.1 Overview
- 8.1.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America OTC Drug and Dietary Supplement Market Analysis – by Form
9.1 Tablets
- 9.1.1 Overview
- 9.1.2 Tablets: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Capsules
- 9.2.1 Overview
- 9.2.2 Capsules: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Powders
- 9.3.1 Overview
- 9.3.2 Powders: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Ointments
- 9.4.1 Overview
- 9.4.2 Ointments: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Liquid
- 9.5.1 Overview
- 9.5.2 Liquid: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America OTC Drug and Dietary Supplement Market Analysis – by Distribution Channel
10.1 Hospital and Retail Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital and Retail Pharmacies: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Retail Stores
- 10.2.1 Overview
- 10.2.2 Retail Stores: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Online Channels
- 10.3.1 Overview
- 10.3.2 Online Channels: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. North America OTC Drug and Dietary Supplement Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America OTC Drug and Dietary Supplement Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 North America OTC Drug and Dietary Supplement Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.1.2 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.1.3 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.1.4 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.2 Canada:
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.2.3 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.2.4 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.3 Mexico :
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.3.3 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.3.4 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 GlaxoSmithKline plc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sanofi
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Abbott
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AbbVie Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bausch Health Companies Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bayer AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Procter & Gamble
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Novartis AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Reckitt Benckiser Group Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America OTC Drug and Dietary Supplement Market
